"TRAcheostomy With Single Use Bronchoscopes vs. Conventional Bronchoscopes" (TraSUB)
Primary Purpose
Respiratory Insufficiency
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Single Use Bronchoscopy for PDT
Conventional Multi Use Bronchoscopy for PDT
Sponsored by
About this trial
This is an interventional treatment trial for Respiratory Insufficiency focused on measuring tracheotomy, bronchoscopy, critical care
Eligibility Criteria
Inclusion Criteria:
- Patients receiving percutaneous tracheotomy in the Dept. of Intensive Care Medicine.
- Age ≥ 18 years
- Informed consent
Exclusion Criteria:
- Age < 18 years
- No consent
- Direct laryngoscopy according to Cormack-Lehane ≥ 3
Sites / Locations
- Universitätsklinikum Hamburg-Eppendorf
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Single Use Bronchoscopy
Conventional Multi Use Bronchoscopy
Arm Description
optical guidance of percutaneous tracheotomy is done by single use bronchoscopy
optical guidance of percutaneous tracheotomy is done by conventional multi use bronchoscopy
Outcomes
Primary Outcome Measures
Visualisation
visualisation through the single use bronchoscope of endotracheal landmark structures for tracheotomy and visualization of the needle insertion (according to score) Scale Name: Rating A) Identification of: thyroid cartilage, cricoid cartilage, 1st-3rd tracheal cartilage 1 Reliable identification; 2 Only cricoid cartilage and tracheal cartilages; 3 Only tracheal cartilages; 4 No vision on tracheal structures B) Visualization of tracheal circumference 1 Complete; 2 circumference 1/3 to 2/3 of circumference; 3 Only small parts of trachea; 4 No vision on tracheal structures C) Monitoring puncture: midline + level below 1st or 2nd tracheal cartilage
1 Reliable identification; 2 Midline sure Level uncertain, but below the 1st tracheal cartilage; 3 Level of puncture uncertain; 4 No vision on tracheal structures D) Monitoring dilatation Anterior wall and Pars membranacea (P.m.) visible; 1 Reliable identification; 2 P.m. only; 3 Only small parts of trachea visible, no control of P.
Secondary Outcome Measures
Minute ventilation
minute ventilation (according to score)
Scale Name: Quality of Ventilation
1 Minute ventilation (MV) as before starting tracheotomy; 2 MV < 2 L/min or oxygen saturation (SO2) 80-90% (>2minutes); 3 MV < 0,5l /min or SO2 70 - 79% (> 2 minutes); 4 MV = 0 or SO2 < 70% (> 2 minutes)
Peak airway pressure
changes in peak airway pressure of ventilator if volume controlled mode is used
Measurement during following time Points:
Measurements of Peak airway pressure before sterile drapes are applied; preintervention
Measurement of Changes in Peak airway pressure before Skin incision and during identification of landmark structures
Measure of Peak airway pressure after Insertion of the tracheal canula
pH
change in pH-values
Measurement during following time Points:
Measurements of pH values before sterile drapes are applied; preintervention
Measurement of Changes in pH values before Skin incision and during identification of landmark structures
Measurement of pH values after Insertion of the tracheal canula
paO2
Change in paO2 values
Measurement during following time Points:
Measurements of paO2 values before sterile drapes are applied; preintervention
Measurement of Changes in paO2 values before Skin incision and during identification of landmark structures
Measurement of paO2 values after Insertion of the tracheal canula
paCO2
Change in paCO2 values
Measurement during following time Points:
Measurements of paCO2 values before sterile drapes are applied; preintervention
Measurement of Changes in paCO2 values before Skin incision and during identification of landmark structures
Measurement of paCO2 values after Insertion of the tracheal canula
etCO2
Change in etCO2 values
Measurement during following time Points:
Measurements of etCO2 values before sterile drapes are applied; preintervention
Measurement of Changes in etCO2 values before Skin incision and during identification of landmark structures
Measurement of etCO2 values after Insertion of the tracheal canula
Duration of intervention
Duration of Intervention
Measurement of Duration of Intervention from Skin incision till Insertion of tracheal cannula (measured in minutes)
Poor visualisation
Poor visualisation with single use bronchoscopy Poor identification thyroid cartilage, cricoid cartilage, 1st-3rd tracheal cartilage : Only identification of tracheal cartilages; No vision possible on tracheal structures Poor visualization of tracheal circumference: Only visualisation of small parts of trachea; No vision on tracheal structures
Poor monitoring of puncture: midline + level below 1st or 2nd tracheal cartilage
: Level of puncture uncertain; No vision on tracheal structures Poor Monitoring of Dilatation: Only small parts of trachea visible, no control of P.m.; No vision on tracheal structures
Poor control
Poor control of the single use bronchoscope:
Intubation of only one bronchial Segment not possible; Intubation of more than one bronchial Segment not possible.
adverse events
any adverse events that are likely associated with tracheostomy
Full Information
NCT ID
NCT03952247
First Posted
April 28, 2019
Last Updated
November 16, 2019
Sponsor
Universitätsklinikum Hamburg-Eppendorf
1. Study Identification
Unique Protocol Identification Number
NCT03952247
Brief Title
"TRAcheostomy With Single Use Bronchoscopes vs. Conventional Bronchoscopes"
Acronym
TraSUB
Official Title
Prospective, Randomized Study in Ventilated Critically Ill Patients Receiving Percutaneous Tracheotomy. A Comparison of Periinterventional Visualization of Conventional Bronchoscopy and Single Use Bronchoscopy (TraSUB™)
Study Type
Interventional
2. Study Status
Record Verification Date
November 2019
Overall Recruitment Status
Completed
Study Start Date
May 15, 2019 (Actual)
Primary Completion Date
November 1, 2019 (Actual)
Study Completion Date
November 4, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Universitätsklinikum Hamburg-Eppendorf
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Optical guidance for percutaneous tracheostomy in intensive care is usually performed by conventional multi use bronchoscopy. Recently a single use bronchoscope has been introduced that allows for endotracheal visualization.
For feasibility evaluation, 23 patients in intensive care receive percutaneous tracheostomy with optical guidance by the Ambu® aScopeTM 4 bronchoscope and 23 patients in intensive care receive percutaneous tracheostomy with a conventional bronchoscope (Olympus BF Type P60). The primary end point is the visualization through the single use bronchoscope of endotracheal landmark structures for tracheostomy and visualization of the needle insertion (according to score, see detailed description).
Detailed Description
Background Long-term ventilated critically ill patients often receive a tracheostomy to facilitate weaning from the ventilator and for prevention of secondary complications by the endotracheal tube. Besides surgical tracheostomy in which a muco-cutaneous fistula is prepared between trachea and outer skin, percutaneous tracheostomy (PDT) has been introduced, in which a cannula is being inserted into the trachea. After introduction of a guidewire, the trachea is then dilated. This intervention should be led by optical guidance, i. e. to verify the correct point of tracheal cannulation between the 2nd and 3rd tracheal cartilage and to minimize the risk for accidental injury to the membranous part of the trachea. Usually, optical guidance is performed by conventional multi use bronchoscopy. During bronchoscopy in ventilated patients, a drop in minute ventilation or an increase of carbon dioxide partial pressure with a consecutive respiratory acidosis may occur. Recently, a single use bronchoscope has been introduced that permits a continuous visualisation of the trachea on a monitor connected to the camera (Ambu® aScopeTM 4, Ambu, Ballerup, Denmark) . In this study, it is being evaluated whether the optical guidance during PDT can be performed by the Ambu® aScope 4. The advantage of a single use bronchoscope for percutaneous dilatative tracheostomy in comparison to a conventional reuseable bronchoscope is that there is no need for repair or decontamination after use.
Methods:
Design of Study/ No. of Patients:
Randomized, prospective study/ 46 patients With a sample size of 46 (randomized 1:1 in 2 groups of 23 each) a difference of 35% on a visualization score [6] may be seen with an α-error of 0,05 and a β-error of 1-0,8.
Procedures:
screening for study inclusion according to inclusion and exclusion criteria.
Percutaneous tracheostomy with Ciaglia Blue Rhino technique
Visualization of PDT via a conventional multi use bronchoscope vs the aScopeTM 4 single use bronchoscope.
study inclusion: All patients being treated in the Dept. of Intensive Care Medicine receiving percutaneous tracheostomy due to long term ventilation are screened according to inclusion and exclusion criteria.
Details of study-procedures:
Bronchoscopy:
The bronchoscopy for percutaneous tracheostomy is done according to the standard operating procedure of the Dept. for Intensive Care Medicine. Furthermore, during this study the bronchoscopy is done by a physician with an experience of more than 200 bronchoscopies.
Percutaneous Tracheostomy:
The tracheostomy is performed according to the Ciaglia Blue Rhino method(Ciaglia Blue Rhino® G2, Cook Medical, Bloomington, IN, USA). After skin incision and an optional blunt dissection of the subcutaneous tissue, the trachea is cannulated between the 2nd and 3rd tracheal cartilage.
Visualization is provided by a conventional multi use bronchoscope or by a single use bronchoscope. Should visualization be insufficient by a single use bronchoscope backup is provided by a conventional multi use bronchoscope.
The tracheostomy is performed by an experienced fellow or attending physician. rating of visualization of tracheal structures and ventilation during percutaneous dilatational tracheostomy:
Rating (each item 1 to 4 points)
A) Identification of: thyroid cartilage, cricoid cartilage, 1st-3rd tracheal cartilage:
1 Reliable identification; 2 Only cricoid cartilage and tracheal cartilages; 3 Only tracheal cartilages; 4 No vision on tracheal structures
B) Visualization of tracheal circumference:
1 Complete; 2 circumference 1/3 to 2/3 of circumference; 3 Only small parts of trachea; 4 No vision on tracheal structures
C) Monitoring puncture: midline + level below 1st or 2nd tracheal cartilage:
1 Reliable identification; 2 Midline sure Level uncertain, but below the 1st tracheal cartilage; 3 Level of puncture uncertain; 4 No vision on tracheal structures
D) Monitoring dilatation Anterior wall and Pars membranacea (P.m.) visible:
1 Reliable identification; 2 P.m. only; 3 Only small parts of trachea visible, no control of P.m.; 4 No vision on tracheal structures
E) Quality of Ventilation Before puncture and worst ventilation during PDT, respectively:
1 Minute ventilation (MV) as before starting tracheotomy; 2 MV < 2 L/min or oxygen saturation (SO2) 80-90% (>2minutes); 3 MV < 0,5l /min or SO2 70 - 79% (> 2 minutes); 4 MV = 0 or SO2 < 70% (> 2 minutes)
F) Quality of the suction channel:
1 Uncomplicated suction of secretion; 2 suction only under flush; 3 suction only possible after multiple removing and flushing of the bronchoscope.; 4 suction not possible.
Consent: all patients or their legal surrogate give written informed consent.
Data protection: Data are anonymized.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Insufficiency
Keywords
tracheotomy, bronchoscopy, critical care
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
46 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Single Use Bronchoscopy
Arm Type
Experimental
Arm Description
optical guidance of percutaneous tracheotomy is done by single use bronchoscopy
Arm Title
Conventional Multi Use Bronchoscopy
Arm Type
Active Comparator
Arm Description
optical guidance of percutaneous tracheotomy is done by conventional multi use bronchoscopy
Intervention Type
Device
Intervention Name(s)
Single Use Bronchoscopy for PDT
Intervention Description
optical guidance of percutaneous tracheotomy is done by single use bronchoscopy
Intervention Type
Device
Intervention Name(s)
Conventional Multi Use Bronchoscopy for PDT
Intervention Description
optical guidance of percutaneous tracheotomy is done by conventional multi use bronchoscopy
Primary Outcome Measure Information:
Title
Visualisation
Description
visualisation through the single use bronchoscope of endotracheal landmark structures for tracheotomy and visualization of the needle insertion (according to score) Scale Name: Rating A) Identification of: thyroid cartilage, cricoid cartilage, 1st-3rd tracheal cartilage 1 Reliable identification; 2 Only cricoid cartilage and tracheal cartilages; 3 Only tracheal cartilages; 4 No vision on tracheal structures B) Visualization of tracheal circumference 1 Complete; 2 circumference 1/3 to 2/3 of circumference; 3 Only small parts of trachea; 4 No vision on tracheal structures C) Monitoring puncture: midline + level below 1st or 2nd tracheal cartilage
1 Reliable identification; 2 Midline sure Level uncertain, but below the 1st tracheal cartilage; 3 Level of puncture uncertain; 4 No vision on tracheal structures D) Monitoring dilatation Anterior wall and Pars membranacea (P.m.) visible; 1 Reliable identification; 2 P.m. only; 3 Only small parts of trachea visible, no control of P.
Time Frame
during tracheotomy
Secondary Outcome Measure Information:
Title
Minute ventilation
Description
minute ventilation (according to score)
Scale Name: Quality of Ventilation
1 Minute ventilation (MV) as before starting tracheotomy; 2 MV < 2 L/min or oxygen saturation (SO2) 80-90% (>2minutes); 3 MV < 0,5l /min or SO2 70 - 79% (> 2 minutes); 4 MV = 0 or SO2 < 70% (> 2 minutes)
Time Frame
two time points: 1. during identification of landmark structures before puncture of trachea, 2. during puncture, dilatation and tracheotomy
Title
Peak airway pressure
Description
changes in peak airway pressure of ventilator if volume controlled mode is used
Measurement during following time Points:
Measurements of Peak airway pressure before sterile drapes are applied; preintervention
Measurement of Changes in Peak airway pressure before Skin incision and during identification of landmark structures
Measure of Peak airway pressure after Insertion of the tracheal canula
Time Frame
three time points: baseline value (before sterile drapes are applied), 0 min before skin incision, and 0 min after insertion of tracheal cannula
Title
pH
Description
change in pH-values
Measurement during following time Points:
Measurements of pH values before sterile drapes are applied; preintervention
Measurement of Changes in pH values before Skin incision and during identification of landmark structures
Measurement of pH values after Insertion of the tracheal canula
Time Frame
three time points: baseline value (before sterile drapes are applied), 0 min before skin incision, and 0 min after insertion of tracheal cannula
Title
paO2
Description
Change in paO2 values
Measurement during following time Points:
Measurements of paO2 values before sterile drapes are applied; preintervention
Measurement of Changes in paO2 values before Skin incision and during identification of landmark structures
Measurement of paO2 values after Insertion of the tracheal canula
Time Frame
three time points: baseline value (before sterile drapes are applied), 0 min before skin incision, and 0 min after insertion of tracheal cannula
Title
paCO2
Description
Change in paCO2 values
Measurement during following time Points:
Measurements of paCO2 values before sterile drapes are applied; preintervention
Measurement of Changes in paCO2 values before Skin incision and during identification of landmark structures
Measurement of paCO2 values after Insertion of the tracheal canula
Time Frame
three time points: baseline value (before sterile drapes are applied), 0 min before skin incision, and 0 min after insertion of tracheal cannula
Title
etCO2
Description
Change in etCO2 values
Measurement during following time Points:
Measurements of etCO2 values before sterile drapes are applied; preintervention
Measurement of Changes in etCO2 values before Skin incision and during identification of landmark structures
Measurement of etCO2 values after Insertion of the tracheal canula
Time Frame
three time points: baseline value (before sterile drapes are applied), 0 min before skin incision, and 0 min after insertion of tracheal cannula
Title
Duration of intervention
Description
Duration of Intervention
Measurement of Duration of Intervention from Skin incision till Insertion of tracheal cannula (measured in minutes)
Time Frame
during tracheotomy (skin incision till insertion of tracheal cannula)
Title
Poor visualisation
Description
Poor visualisation with single use bronchoscopy Poor identification thyroid cartilage, cricoid cartilage, 1st-3rd tracheal cartilage : Only identification of tracheal cartilages; No vision possible on tracheal structures Poor visualization of tracheal circumference: Only visualisation of small parts of trachea; No vision on tracheal structures
Poor monitoring of puncture: midline + level below 1st or 2nd tracheal cartilage
: Level of puncture uncertain; No vision on tracheal structures Poor Monitoring of Dilatation: Only small parts of trachea visible, no control of P.m.; No vision on tracheal structures
Time Frame
during tracheotomy
Title
Poor control
Description
Poor control of the single use bronchoscope:
Intubation of only one bronchial Segment not possible; Intubation of more than one bronchial Segment not possible.
Time Frame
during tracheotomy
Title
adverse events
Description
any adverse events that are likely associated with tracheostomy
Time Frame
up to 1 week
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients receiving percutaneous tracheotomy in the Dept. of Intensive Care Medicine.
Age ≥ 18 years
Informed consent
Exclusion Criteria:
Age < 18 years
No consent
Direct laryngoscopy according to Cormack-Lehane ≥ 3
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jörn Grensemann, MD
Organizational Affiliation
Dept. of Intensive Care Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universitätsklinikum Hamburg-Eppendorf
City
Hamburg
State/Province
HH
ZIP/Postal Code
20246
Country
Germany
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
24668495
Citation
Dreher M, Kluge S. [Airway devices in the intensive care unit]. Pneumologie. 2014 Jun;68(6):371-7. doi: 10.1055/s-0034-1365318. Epub 2014 Mar 25. German.
Results Reference
background
PubMed Identifier
3996056
Citation
Ciaglia P, Firsching R, Syniec C. Elective percutaneous dilatational tracheostomy. A new simple bedside procedure; preliminary report. Chest. 1985 Jun;87(6):715-9. doi: 10.1378/chest.87.6.715.
Results Reference
background
PubMed Identifier
21630175
Citation
Braune S, Kluge S. [Percutaneous dilatational tracheostomy]. Dtsch Med Wochenschr. 2011 Jun;136(23):1265-9. doi: 10.1055/s-0031-1280549. Epub 2011 May 31. No abstract available. German.
Results Reference
background
PubMed Identifier
26271742
Citation
Vargas M, Sutherasan Y, Antonelli M, Brunetti I, Corcione A, Laffey JG, Putensen C, Servillo G, Pelosi P. Tracheostomy procedures in the intensive care unit: an international survey. Crit Care. 2015 Aug 13;19(1):291. doi: 10.1186/s13054-015-1013-7.
Results Reference
background
PubMed Identifier
29284503
Citation
Grensemann J, Eichler L, Kahler S, Jarczak D, Simon M, Pinnschmidt HO, Kluge S. Bronchoscopy versus an endotracheal tube mounted camera for the peri-interventional visualization of percutaneous dilatational tracheostomy - a prospective, randomized trial (VivaPDT). Crit Care. 2017 Dec 29;21(1):330. doi: 10.1186/s13054-017-1901-0.
Results Reference
background
PubMed Identifier
20857374
Citation
Baumann HJ, Kemei C, Kluge S. [Tracheostomy in the intensive care unit]. Pneumologie. 2010 Dec;64(12):769-76. doi: 10.1055/s-0030-1255743. Epub 2010 Sep 20. German.
Results Reference
background
PubMed Identifier
11004042
Citation
Byhahn C, Wilke HJ, Halbig S, Lischke V, Westphal K. Percutaneous tracheostomy: ciaglia blue rhino versus the basic ciaglia technique of percutaneous dilational tracheostomy. Anesth Analg. 2000 Oct;91(4):882-6. doi: 10.1097/00000539-200010000-00021.
Results Reference
background
PubMed Identifier
20357150
Citation
Linstedt U, Zenz M, Krull K, Hager D, Prengel AW. Laryngeal mask airway or endotracheal tube for percutaneous dilatational tracheostomy: a comparison of visibility of intratracheal structures. Anesth Analg. 2010 Apr 1;110(4):1076-82. doi: 10.1213/ANE.0b013e3181d27fb4.
Results Reference
background
PubMed Identifier
35366806
Citation
Tariparast PA, Brockmann A, Hartwig R, Kluge S, Grensemann J. Percutaneous dilatational tracheostomy with single use bronchoscopes versus reusable bronchoscopes - a prospective randomized trial (TraSUB). BMC Anesthesiol. 2022 Apr 2;22(1):90. doi: 10.1186/s12871-022-01618-4.
Results Reference
derived
Learn more about this trial
"TRAcheostomy With Single Use Bronchoscopes vs. Conventional Bronchoscopes"
We'll reach out to this number within 24 hrs